Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiology

NeuroReport

Volumn 11, Issue 5, 2000, Pages 987-991

  Reiman, Eric M ^a,d   Uecker, Anne ^d   Gonzalez Lima, F ^c   Minear, Deanna ^d   Chen, Kewei ^a,b,d   Callaway, Narriman Lee ^c   Berndt, Jason D ^c   Games, Dora ^d  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d Harrington Arthritis Research Center   (United States)

Author keywords

Alzheimer's disease; Animal models; Autoradiography; Cerebral metabolic rate for glucose; Functional brain imaging; Positron emission tomography; Posterior cingulate cortex; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; FLUORODEOXYGLUCOSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; TISSUE DISTRIBUTION;

EID: 0034616277     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004070-00018     Document Type: Article

References (25)

1. 1. Games D, Adams D, Alessandri R et al. Nature 373, 523-527 (1995).
2. 2. Bierer LM, Hof PR, Purohit DP et al. Arch Neurol 52, 81-88 (1995).
3. 3. Minoshima S, Foster NL and Kuhl DE. Lancet 344, 895 (1994).
4. 4. Minoshima S, Giordani B, Berent S et al. Ann Neurol 42, 85-94 (1997).
5. 5. Reiman EM, Caselli RJ, Lang SY et al. New Engl J Med 334, 752-758 (1996).
6. 6. Haxby JV. In: Positron Emission Tomography in Dementia. New York: Wiley-Liss, 1990: 93-116.
7. 7. Minoshima S, Frey KA, Foster NL et al. J Comput Assist Tomogr 19, 541-547 (1995).
8. 8. Mielke R, Herholz K, Grond M et al. Dementia 5, 36-41 (1994).
9. 9. Brun A and Gustafson L. Arch Psychiatr Nervenkr 223, 15-33 (1976).
10. 10. Vogt BA, Van Hoesen GW and Vogt LJ. Acta Neuropathol 80, 581-589 (1990).
11. 11. Braak H and Braak E. Acta Neuropathol 82, 239-259 (1991).
12. 12. Vogt BA, Pandya DN and Rosene DL. J Comp Neurol 262, 256-270 (1987).
13. 13. Gonzalez-Lima F, Helmstetter FJ and Agudo J. Physiol Behav 54, 605-612 (1993).
14. 14. Gonzalez-Lima F and Cada A. Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease. New York: Plenum Press, 1998: 263-280.
15. 15. Schwartz WJ, Smith CB, Davidsen L et al. Science 205, 723-725 (1979).
16. 16. Magistretti PJ and Pellerin L. Cerebr Cortex 6, 50-61 (1996).
17. 17. Piert M, Koeppe RA, Giordani B et al. J Nucl Med 37, 201-208 (1996).
18. 18. Mark RJ, Pang Z, Geddes JW et al. J Neurosci 17, 1046-1054 (1997).
19. 19. Ibáñez V, Pietrini P, Alexander GE et al. Neurology 50, 1585-1593 (1998).
20. 20. Hyman BT, Van Hoesen GW, Kromer LJ et al. Ann Neurol 20, 472-481 (1986).
21. 21. Insausti R, Herrero MT and Witter MP. Hippocampus 7, 146-183 (1997).
22. 22. Vogt BA, Sikes RW, Swadlow HA et al. J Comp Neurol 248, 74-94 (1986).
23. 23. Gabriel M, Sparenborg SP and Stolar N. Exp Brain Res 67, 131-152 (1987).
24. 24. Gabriel M and Sparenborg SP. Brain Res 409, 151-157 (1987).
25. 25. Schenk D, Barbour R, Dunn W et al. Nature 400, 173-177 (1999).